Summary hMLH1 and hPMS2 are part of the DNA mismatch repair complex. Mutations in these genes have been linked to hereditary nonpolyposis colon cancer; they also occur in a variety of sporadic cancers. Western blot analysis and immunohistochemistry demonstrated that hMLH1 and hPMS2 are widely expressed nuclear proteins with a distribution pattern very similar to that previously described for hMSH2.
Microsatellite instability has been observed in most tumours arising in patients with hereditary non-polyposis colorectal cancer (HNPCC) and in many sporadic colon, gastric, endometrial, ovarian and small-cell lung carcinomas (reviewed by Loeb, 1994) . Microsatellite alterations in such tumours have been postulated to arise through somatic mutations as a result of loss of the DNA mismatch repair activity that produces a replication error phenotype (Aaltonen et al, 1993) . Mutations in any one of four human DNA mismatch repair genes (hMSH2, hMLH1, hPMS 1 and hPMS2) have been linked to HNPCC (Fishel et al, 1993; Bronner et al, 1994; Nicolaides et al, 1994) . MSH2 and GTBP form a heterodimer that binds to mismatched bases (Palombo et al, 1995) and that serves to recruit a heterodimer of hMLH1 and hPMS2 and free hPMSl to the complex (Prolla et al, 1994; Li and Modrich, 1995) . Recently, Wilson et al (1995) and Leach et al (1996) demonstrated using immunohistochemistry a particularly prominent staining of the hMSH2 protein in the epithelium of the digestive tract, extending from the oesophagus to the rectum. Mello et al (1996) observed using Western blot analysis the highest expression of hMSH2 in testis and ovary.
There is as yet no information on the expression of hMLH1 and hPMS2 proteins in normal human tissues. Using specific antibodies for hMLHI and hPMS2, we report here that these proteins are localized in the nucleus and are highly expressed in the epithelium of the digestive tract and in the testis and ovary. These observations showing similar localization of hMLHl and hPMS2 with hMSH2 emphasize the combined role of these proteins in the DNA mismatch repair system. (Koi et al, 1994) . The cell lines were maintained in Iscove's modified Dulbecco's medium (Irvine Scientific, Irvine, CA, USA) supplemented with 2 mM L-glutamine and 10% heatinactivated fetal bovine serum. The chromosome-complemented lines were maintained in medium supplemented with geneticine (400 jg ml-') (Life Technologies, Gaithersburg, MD, USA). Frozen tissues were obtained from surgical resections and stored at -70°C until used.
MATERIALS AND METHODS

Western blot analysis
Cells were lysed on ice in 150 mm sodium chloride containing 5 mm EDTA, 1% Triton X-100, 10 mm Tris/HCl (pH 7.4), 5 mm DTT, 0.1 mm phenylmethylsulphonyl fluoride and 5 mm c-aminocaproic acid. After centrifugation, 100 jig of protein was denatured by boiling in an equal volume of 130 mm Tris/HCl (pH 6.8) containing 20% glycerol, 4.6% sodium dodecyl sulphate (SDS) and 0.02% bromophenol blue. The proteins were separated using SDS-PAGE on an 8% gel, followed by electroblotting onto a polyvinylidene difluoride membrane (Immobilon P; Millipore, Bedford, MA, USA). hMLH1 was detected using the mouse monoclonal antihMLHI antibody (clone G168-15, PharMingen, San Diego, CA, USA) at a concentration of 2 jig ml-', followed by horseradish peroxidase-conjugated anti-mouse antibody (Amersham, Arlington Heights, IL, USA) and hPMS2 was detected with the rabbit polyclonal anti-hPMS2 (E-19, Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a concentration of 2 jig ml', followed by horseradish peroxidase-conjugated anti-rabbit antibody (Amersham) and generation of chemoluminescence by enhanced chemoluminescence (ECL) (Amersham).
Immunohistochemistry
Frozen sections were fixed in 10% buffered formalin for 20 min and then washed in buffer. in 10% goat serum for 10 min. After two 5-min PBS washes, the sections were incubated with prediluted streptavidin-conjugated horseradish peroxidase (Dako) for 10 min. The sections were then incubated with the chromogen 3-amino-9-ethylcarbazole (Sigma Chemical, St Louis, MO, USA). Antibody to vimentin was used as a positive control. The sections were counterstained with a haematoxylin.
RESULTS
Western blot analysis
The specificity of the hMLHl antibody was examined using protein extracts from the HCT1 16+ch2 and HCT1 16+ch3 cells. Using immunoblot analysis, the hMLHl antibody reacted with a single protein of Mr 85 000, consistent with the reported molecular weight of hMLHl, which was present in lysates from the HCT116+ch3 cells but not the HCT116+ch2 cells ( Figure IA) . The PMS2 antibody detected a single protein of Mr 105 000, which is consistent with the reported molecular weight of hPMS2 ( Figure  1B ). The expression of hMLH1 and hPMS2 was determined by Western blot analysis of proteins prepared from normal human tissues from each of the major organ systems. The highest expression of both hMLHI and hPMS2 was found in the testis and the ovary (Figure 1 ). Lower levels of expression were observed in brain, adrenal, heart, stomach, small intestine, skeletal muscle, liver, kidney, spleen and prostate (data not shown).
Immunohistochemistry
Immunohistochemistry demonstrated that the localization of both hMLHI and hPMS2 was exclusively nuclear in all tissues examined. Nuclear staining was evident in many different human tissues, including adrenal cortex, kidney, exocrine pancreas, prostate and spleen. The expression of hMLHl and hPMS2 was very prominent in the proliferating epithelia of the digestive tract (Figure 2 A and B) . In agreement with the results of Western blot analysis, there was particularly strong staining of both hMLHI and hPMS2 in the more primitive testicular germ cells (Figure 2 E and F). The nuclei of the Sertoli cells and the Leydig cells did not stain with either antibody. In the ovary, nuclei of the granulosa cells and of a subset of the stromal cells were stained, whereas the surface epithelium and the germ cells were non-reactive (Figure 2  C and D) .
DISCUSSION
Our results demonstrate that hMLHI and hPMS2 are widely and concordantly expressed proteins with an exclusively nuclear localization. As described by Wilson et al (1995) and Leach et al (1996) for hMSH2, the expression of hMLHl and hPMS2 in the digestive tract was limited to the cells in the lower part of the crypts, anticipated to be the replicative fraction, suggesting transcriptional or translational control of expression analogous to that of other proteins involved in the DNA replication. However, in other tissues, nuclear staining was observed in cells that were not clearly limited to just replicative compartments. Consistent with the report by Mello et al (1996) for hMSH2, we found the highest expression of hMLH1 and hPMS2 in the testis and ovary. In the testis, staining was observed exclusively in the early germ cells, whereas in the ovary staining was limited to the granulosa and stromal cells. Because of the importance of transmitting genetic information without errors, it is not surprising to find the highest expression of hMLH1 and hPMS2 in the germ cell of the testis. Baker et al (1995) observed that homozygosity for a null mutation in the DNA mismatch repair gene PMS2 results in a phenotype associated with male sterility due to failure in the process of spermatogenesis, whereas PMS2-deficient female mice appear fully fertile. The results of this study showing a colocalization of hMLHl and hPMS2 with hMSH2 are consistent with the current understanding of the biochemically defined interactions between these proteins and their function in the DNA mismatch repair system. Furthermore, the use of immunohistochemistry may offer a relatively rapid method for prescreening tumours for defects in the expression of mismatch repair genes. 
